Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn’s Disease
Condition(s):Crohn’s DiseaseLast Updated:December 28, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Crohn’s DiseaseLast Updated:December 28, 2021Completed
Condition(s):Metastatic Melanoma; Metastatic Renal Cell Cancer; Metastatic CancerLast Updated:November 19, 2019Terminated
Condition(s):Age Related Macular DegenerationLast Updated:May 3, 2018Completed
Condition(s):Bleeding Peptic UlcerLast Updated:March 8, 2016Completed
Condition(s):Ulcer BleedingLast Updated:July 15, 2020Terminated
Condition(s):Breast NeoplasmsLast Updated:February 16, 2015Completed
Condition(s):Gastro-enteropancreatic Neuroendocrine TumorLast Updated:March 15, 2024Active, not recruiting
Condition(s):Tuberculosis, PulmonaryLast Updated:February 13, 2020Completed
Condition(s):Osteoarthritis (OA)Last Updated:March 2, 2020Completed
Condition(s):Uveitis Related Cystoid Macular Edema; Cystoid Macular Edema, PostoperativeLast Updated:November 22, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.